These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6116497)

  • 61. [Myocardial function and the use of propranolol in ischemic heart disease].
    Sidorenko BA; Kasatkina LV; Lupanov VP; Mazaev VP
    Kardiologiia; 1979 Aug; 19(8):70-3. PubMed ID: 491363
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Therapy of coronary heart disease].
    Niederberger M
    Wien Med Wochenschr; 1976 Aug; 126(32-35):469-73. PubMed ID: 11611
    [No Abstract]   [Full Text] [Related]  

  • 63. [Effects of beta adrenergic receptor blockaders studied with propranolol on the ventricular repolarizzation in patients with hypertensive heart disease and chronic coronary insufficiency].
    Zani D; Melara D
    Cardiol Prat; 1969 Jun; 20(3):211-27. PubMed ID: 5407605
    [No Abstract]   [Full Text] [Related]  

  • 64. [Current treatment of chronic ischemic heart disease].
    Möckel S
    Z Arztl Fortbild (Jena); 1977 Apr; 71(8):386-8. PubMed ID: 17955
    [No Abstract]   [Full Text] [Related]  

  • 65. [Combined administration of obzidan and sustak in the treatment of patients with chronic coronary insufficiency].
    Khalfen ESh; Sorokina VS; Iaikova MM
    Ter Arkh; 1974; 46(1):73-7. PubMed ID: 4217951
    [No Abstract]   [Full Text] [Related]  

  • 66. [Differentiated therapy of patients with chronic coronary insufficiency].
    Miasnikov LA; Metelitsa VI
    Ter Arkh; 1969 Apr; 41(4):74-82. PubMed ID: 4191108
    [No Abstract]   [Full Text] [Related]  

  • 67. [Evaluation of propanolol in the treatment of coronary disease].
    Januszewicz W; Sznajderman M; Poplawska W
    Pol Arch Med Wewn; 1966; 36(6):777-81. PubMed ID: 4957910
    [No Abstract]   [Full Text] [Related]  

  • 68. [Effect of nitroglycerin administration on serum lysozyme level during the treatment of acute ischemic heart disease].
    Sielańczyk A
    Pol Tyg Lek; 1986 Oct; 41(41):1303-5. PubMed ID: 3103112
    [No Abstract]   [Full Text] [Related]  

  • 69. [On the effect of the acute administration of propranolol on the electrocardiogram during exercise in chronic coronary disease].
    Lixi M; Raffo M; Porrazzo G; Camoglio E; Cuozzo G; Cherchi A
    Boll Soc Ital Cardiol; 1966; 11(4):1523-9. PubMed ID: 5992068
    [No Abstract]   [Full Text] [Related]  

  • 70. [Use of nitroglycerin in patients after surgical treatment of coronary disease].
    Golański R; Iwaszkiewicz A; Kesiak J; Rychter J; Godlewska H; Rachalewski A; Jegier B
    Pol Tyg Lek; 1986 Jun 23-30; 41(25-26):825-8. PubMed ID: 3095800
    [No Abstract]   [Full Text] [Related]  

  • 71. [Echocardiographic study of left ventricular function during treatment with oral quinidine].
    Guadagni C; Bosi S; Coccolini S
    Minerva Cardioangiol; 1987; 35(1-2):83-5. PubMed ID: 3561814
    [No Abstract]   [Full Text] [Related]  

  • 72. [Propranolol in the treatment of coronary disease].
    Markiewicz M; Korolko A
    Pol Tyg Lek; 1972 May; 27(20):744-5. PubMed ID: 5029664
    [No Abstract]   [Full Text] [Related]  

  • 73. [Beta blockaders and facial vascular pain (apropos of 4 cases)].
    Serratrice G; Cremieux G
    Nouv Presse Med; 1973 Feb; 2(7):445. PubMed ID: 4143903
    [No Abstract]   [Full Text] [Related]  

  • 74. [Characteristics of the apexcardiogram in healthy forty-year-old people and in patients with coronary disease (its response to nitroglycerin)].
    Hugo Dejo B; Ricardo Alvarez M; Gustavo Rivada R; Koga H; Alzamora MA; Alvarado O
    Rev Esp Cardiol; 1967 Jul; 20(3):289-308. PubMed ID: 4972838
    [No Abstract]   [Full Text] [Related]  

  • 75. [Use of adenylate cyclase inhibitors for treating myopathies].
    Il'ina NA; Khokhlov AP; Poliakova NF; Antipova RI
    Sov Med; 1980; (8):86-9. PubMed ID: 6106969
    [No Abstract]   [Full Text] [Related]  

  • 76. [Directed measures of the ambulatory scope of improvement of stationary care from the viewpoint of a specialist for cardiovascular diseases].
    Fiehring H
    Z Arztl Fortbild (Jena); 1974 Apr; 68(7):340-2. PubMed ID: 4153192
    [No Abstract]   [Full Text] [Related]  

  • 77. [Beta receptor blockage with special reference to propranolol].
    Hübner A
    Dtsch Gesundheitsw; 1969 Mar; 24(8):350-3. PubMed ID: 5376403
    [No Abstract]   [Full Text] [Related]  

  • 78. [Use of alprenolol in coronary disease].
    Tricot R; Valère PE
    Ann Med Interne (Paris); 1971 Feb; 122(2):233-6. PubMed ID: 4397123
    [No Abstract]   [Full Text] [Related]  

  • 79. [Contractile function of the myocardium during treatment of arteriosclerotic cardiosclerosis with methimazole].
    Neĭko EM; Vandzhura IP; Kupnovitskaia IG; Debenko MV
    Vrach Delo; 1978 Jun; (6):22-6. PubMed ID: 695463
    [No Abstract]   [Full Text] [Related]  

  • 80. [Therapy of coronary disease with sorbonit and propranolol].
    Chojnowski JR; Adamska-Dyniewska H; Goch JH
    Wiad Lek; 1970 Feb; 23(3):203-7. PubMed ID: 5417598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.